Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1946 1
1947 1
1948 3
1949 5
1950 10
1951 6
1952 5
1953 1
1954 12
1955 16
1956 15
1957 4
1958 5
1959 6
1960 4
1961 17
1962 24
1963 6
1964 15
1965 15
1966 13
1967 16
1968 10
1969 17
1970 10
1971 19
1972 18
1973 9
1974 8
1975 16
1976 12
1977 7
1978 15
1979 14
1980 13
1981 16
1982 21
1983 23
1984 19
1985 26
1986 16
1987 14
1988 20
1989 15
1990 14
1991 23
1992 20
1993 13
1994 16
1995 24
1996 15
1997 30
1998 42
1999 44
2000 45
2001 46
2002 54
2003 51
2004 57
2005 60
2006 53
2007 61
2008 80
2009 108
2010 103
2011 128
2012 123
2013 130
2014 154
2015 148
2016 142
2017 166
2018 133
2019 146
2020 141
2021 164
2022 136
2023 129
2024 132

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,137 results

Results by year

Filters applied: . Clear all
Page 1
Expanding the phenotype and genotype in Thauvin-Robinet-Faivre syndrome: A new patient with a novel variant and additional clinical findings.
Duzenli T, Sezer A, Kayhan G, Arslan AT, Percin FE. Duzenli T, et al. Am J Med Genet A. 2023 Aug;191(8):2232-2239. doi: 10.1002/ajmg.a.63300. Epub 2023 May 23. Am J Med Genet A. 2023. PMID: 37218527
Thauvin-Robinet-Faivre syndrome (TROFAS; OMIM #617107) is a rare autosomal recessive overgrowth syndrome characterized by generalized overgrowth, dysmorphic facial features, and delayed psychomotor development caused by biallelic pathogenic variants in the FGF-1 intracellu …
Thauvin-Robinet-Faivre syndrome (TROFAS; OMIM #617107) is a rare autosomal recessive overgrowth syndrome characterized by generalized …
New cases of recently described Thauvin-Robinet-Faivre syndrome with a novel homozygous FIBP gene variant.
Kılıç E, Koşukcu C. Kılıç E, et al. Am J Med Genet A. 2024 Mar;194(3):e63449. doi: 10.1002/ajmg.a.63449. Epub 2023 Oct 24. Am J Med Genet A. 2024. PMID: 37876348
Thauvin-Robinet-Faivre syndrome (#617107) is a rare autosomal recessive overgrowth syndrome characterized by intellectual disability, facial dysmorphism, macrocephaly, and variable congenital malformations. ...Embryonic tumors are especially common in these syndromes. Thau …
Thauvin-Robinet-Faivre syndrome (#617107) is a rare autosomal recessive overgrowth syndrome characterized by intellectual disability, …
Letter to the Editor regarding "New cases of recently described Thauvin-Robinet-Faivre syndrome with a novel homozygous FIBP gene variant" by Kilic and Kosukcu, "An investigation of the etiology and follow-up findings in 35 children with overgrowth syndromes, including biallelic SUZ12 variant" by Yuksel Ulker et al. and "Expanding the phenotype and genotype in Thauvin-Robinet-Faivre syndrome: A new patient with a novel variant and additional clinical findings" by Duzenli et al.
Duzenli T, Sezer A, Percin FE. Duzenli T, et al. Am J Med Genet A. 2024 Apr;194(4):e63507. doi: 10.1002/ajmg.a.63507. Epub 2023 Dec 15. Am J Med Genet A. 2024. PMID: 38102793 No abstract available.
Magnetotactic bacteria and magnetosomes.
Faivre D, Schüler D. Faivre D, et al. Chem Rev. 2008 Nov;108(11):4875-98. doi: 10.1021/cr078258w. Epub 2008 Oct 15. Chem Rev. 2008. PMID: 18855486 Review. No abstract available.
Optimal dynamic regimens with artificial intelligence: The case of temozolomide.
Houy N, Le Grand F. Houy N, et al. PLoS One. 2018 Jun 26;13(6):e0199076. doi: 10.1371/journal.pone.0199076. eCollection 2018. PLoS One. 2018. PMID: 29944669 Free PMC article.
We use a Pharmacokinetics/Pharmacodynamics (PK/PD) model based on Faivre and coauthors (Faivre, et al., 2013) for the pharmacokinetics of temozolomide, as well as the pharmacodynamics of its efficacy. ...
We use a Pharmacokinetics/Pharmacodynamics (PK/PD) model based on Faivre and coauthors (Faivre, et al., 2013) for the pharmaco …
3,137 results